XWELL, Inc.(NASDAQ:XWEL) shares rose 158.10% in after-hours trading on Tuesday to $0.98, following the company's announcement of a private placement expected to generate gross proceeds of approximately $31.3 million, before deducting placement agent fees and offering expenses.
Inside the Deal
XWELL entered into a securities purchase agreement with a series of American Ventures, LLC, a Texas-based real estate investment firm, issuing approximately 31,333 shares of Series H Convertible Preferred Stock with a stated value of $1,000 per share, convertible into 66.66 million shares of common stock at an initial conversion price of $0.47 per share.
The placement also includes accompanying warrants to purchase up to 66.66 million shares, exercisable immediately at $0.345 per share, expiring three years from issuance.
Dominari Securities acted as exclusive placement agent.
Proceeds Earmarked for Debt Repurchase
XWELL said it intends to use the proceeds to repurchase $5.95 million of certain notes from institutional investors, redeem its Series G preferred stock and repurchase warrants to buy up to 8.8 million shares of common stock from institutional investors, for a total cash outlay of $9 million.
The remaining funds will be used for general corporate and working capital needs.
The placement is expected to close on or about Thursday.
Trading Metrics, Technical Analysis
XWELL has a Relative Strength Index (RSI) of 45.99.
The market capitalization of the New York-based health and wellness holding company stands at $2.19 million, with its shares reaching a 52-week high of $1.42 and a low of $0.26.
XWEL has fallen 66.55% over the past 12 months.
Price Action: According to Benzinga Pro data, XWEL closed on Tuesday at $0.38, up 9.63%.
The stock is currently positioned at approximately 10.3% above its 52-week low, indicating it is trading closer to the lower end of its annual range.
Benzinga's Edge Stock Rankings indicate that XWEL has a negative price trend across all time frames.
Photo Courtesy: m.mphoto on Shutterstock.com
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.